The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Trends in Solubility of Polymorphs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Hancock, B. C., & Parks, M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007516718048 · Cited by 1,358
Polymorphism in Pharmaceutical Solids
(2018) · CRC Press eBooks · doi:10.3109/9781420073225 · Cited by 1,099
Solid state chemistry of drugs
Byrn, S. R. (1982) · Medical Entomology and Zoology · Cited by 1,086
Ritonavir: An Extraordinary Example of Conformational Polymorphism
Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W., & Morris, J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011052932607 · Cited by 1,071
Polymorphism in pharmaceutical solids
Giordano, F. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00252-8 · Cited by 671
Solubility and Solubilization in Aqueous Media
Yalkowsky, S. H. (1999) · Cited by 669
Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations
Byrn, S. R., Pfeiffer, R. R., Ganey, M. E., Hoiberg, C. P., & Poochikian, G. (1995) · Pharmaceutical Research · doi:10.1023/a:1016241927429 · Cited by 476
Thermodynamic Driving Force in Nucleation and Growth Processes
Hoffman, J. D. (1958) · The Journal of Chemical Physics · doi:10.1063/1.1744688 · Cited by 439
Dissolution Behavior of Crystalline Solvated and Nonsolvated Forms of Some Pharmaceuticals
Shefter, E., & Higuchi, T. (1963) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600520815 · Cited by 373
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
Babu, N. J., & Nangia, A. (2011) · Crystal Growth & Design · doi:10.1021/cg200492w · Cited by 1,004
Pharmaceutical cocrystals: along the path to improved medicines
Duggirala, N. K., Perry, M. L., Almarsson, Ö., & Zaworotko, M. J. (2016) · Chemical Communications · doi:10.1039/c5cc08216a · Cited by 928
Solubility Advantage of Pharmaceutical Cocrystals
Good, D. J., & Rodríguez-Hornedo, N. (2009) · Crystal Growth & Design · doi:10.1021/cg801039j · Cited by 841
Facts and fictions about polymorphism
Cruz-Cabeza, A. J., Reutzel-Edens, S. M., & Bernstein, J. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00227c · Cited by 678
Pharmaceutical cocrystals and poorly soluble drugs
Thakuria, R., Delori, A., Jones, W., Lipert, M. P., Roy, L., & Rodríguez-Hornedo, N. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.043 · Cited by 614
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs
Censi, R., & Di Martino, P. (2015) · Molecules · doi:10.3390/molecules201018759 · Cited by 512
Bridging solubility between drug discovery and development
Di, L., Fish, P. V., & Mano, T. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.11.007 · Cited by 491
High throughput solubility measurement in drug discovery and development
Alsenz, J., & Kansy, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.007 · Cited by 412
Berry, D. J., & Steed, J. W. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.003 · Cited by 406
Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications
Guo, M., Sun, X., Chen, J., & Cai, T. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.030 · Cited by 386
Solubility of sparingly-soluble ionizable drugs
Avdeef, A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.008 · Cited by 299
Sanphui, P., Goud, N. R., Khandavilli, U. B. R., Bhanoth, S., & Nangia, A. (2011) · Chemical Communications · doi:10.1039/c1cc10204d · Cited by 291
An overview of recent studies on the analysis of pharmaceutical polymorphs
Chieng, N., Rades, T., & Aaltonen, J. (2011) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.12.020 · Cited by 285
Kawakami, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.009 · Cited by 259
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Fast Dissolving Curcumin Cocrystals
Sanphui, P., Goud, N. R., Khandavilli, U. B. R., & Nangia, A. (2011) · Crystal Growth & Design · doi:10.1021/cg200704s · Cited by 253
Metadata
- Authors
- Pudipeddi, M., & Serajuddin, A. T. M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 94
- Issue
- 5
- Pages
- 929-939
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2101212670
- Cited by
- 505
- References
- 16
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.